Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II studyXiangrui Meng, Feng Wang, Zhiquan Luo et al.|European Journal of Cancer|2024Cited by 18
Resveratrol inhibited GH3 cell growth and decreased prolactin level via estrogen receptorsChao Wang, Junsheng Wang, Ming Chu et al.|Clinical Neurology and Neurosurgery|2011Cited by 17